Klarsen reported earnings results for the half year ended June 30, 2022. For the half year, the company reported sales was EUR 0.871 million compared to EUR 0.834 million a year ago. Net income was EUR 0.163 million compared to EUR 0.157 million a year ago.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.642 EUR | -3.98% |
|
-0.73% | -39.63% |
30/04 | Klarsen Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
15/03 | Acticor Biotech Raises EUR8 Million to Fund Emergency Stroke Treatment Development | MT |
1st Jan change | Capi. | |
---|---|---|
-39.63% | 61.85L | |
-8.52% | 20TCr | |
+10.15% | 18TCr | |
+13.32% | 17TCr | |
+5.16% | 9.93TCr | |
+45.66% | 9.18TCr | |
+14.08% | 8.56TCr | |
+11.87% | 8.46TCr | |
+7.06% | 5.08TCr | |
-31.99% | 4.48TCr |
- Stock Market
- Equities
- ALKLA Stock
- News Klarsen
- Klarsen Reports Earnings Results for the Half Year Ended June 30, 2022